Clinical Stage Biotechnology Market, Global Outlook and Forecast 2022-2028

July 2022 | 68 pages | ID: C949C085E70FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Clinical Stage Biotechnology in Global, including the following market information:

Global Clinical Stage Biotechnology Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Clinical Stage Biotechnology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Phase I Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Clinical Stage Biotechnology include Minoryx, Inhibrx, NovaBiotics, RadioMedix, Artax Biopharma, Ribon Therapeutics, Brickell Biotech, Coave Therapeutics and Edesa Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical Stage Biotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Clinical Stage Biotechnology Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Clinical Stage Biotechnology Market Segment Percentages, by Type, 2021 (%)

• Phase I
• Phase II
• Phase III

Global Clinical Stage Biotechnology Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Clinical Stage Biotechnology Market Segment Percentages, by Application, 2021 (%)

• Bio-pharmaceuticals
• Scientific Research

Global Clinical Stage Biotechnology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Clinical Stage Biotechnology Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Clinical Stage Biotechnology revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Clinical Stage Biotechnology revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Minoryx
• Inhibrx
• NovaBiotics
• RadioMedix
• Artax Biopharma
• Ribon Therapeutics
• Brickell Biotech
• Coave Therapeutics
• Edesa Biotech
• CellCentric
• LimmaTech Biologics AG
• Adaptive Phage Therapeutics
• Intra-ImmuSG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Clinical Stage Biotechnology Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Clinical Stage Biotechnology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CLINICAL STAGE BIOTECHNOLOGY OVERALL MARKET SIZE

2.1 Global Clinical Stage Biotechnology Market Size: 2021 VS 2028
2.2 Global Clinical Stage Biotechnology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Clinical Stage Biotechnology Players in Global Market
3.2 Top Global Clinical Stage Biotechnology Companies Ranked by Revenue
3.3 Global Clinical Stage Biotechnology Revenue by Companies
3.4 Top 3 and Top 5 Clinical Stage Biotechnology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Clinical Stage Biotechnology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Stage Biotechnology Players in Global Market
  3.6.1 List of Global Tier 1 Clinical Stage Biotechnology Companies
  3.6.2 List of Global Tier 2 and Tier 3 Clinical Stage Biotechnology Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Clinical Stage Biotechnology Market Size Markets, 2021 & 2028
  4.1.2 Phase I
  4.1.3 Phase II
  4.1.4 Phase III
4.2 By Type - Global Clinical Stage Biotechnology Revenue & Forecasts
  4.2.1 By Type - Global Clinical Stage Biotechnology Revenue, 2017-2022
  4.2.2 By Type - Global Clinical Stage Biotechnology Revenue, 2023-2028
  4.2.3 By Type - Global Clinical Stage Biotechnology Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Clinical Stage Biotechnology Market Size, 2021 & 2028
  5.1.2 Bio-pharmaceuticals
  5.1.3 Scientific Research
5.2 By Application - Global Clinical Stage Biotechnology Revenue & Forecasts
  5.2.1 By Application - Global Clinical Stage Biotechnology Revenue, 2017-2022
  5.2.2 By Application - Global Clinical Stage Biotechnology Revenue, 2023-2028
  5.2.3 By Application - Global Clinical Stage Biotechnology Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Clinical Stage Biotechnology Market Size, 2021 & 2028
6.2 By Region - Global Clinical Stage Biotechnology Revenue & Forecasts
  6.2.1 By Region - Global Clinical Stage Biotechnology Revenue, 2017-2022
  6.2.2 By Region - Global Clinical Stage Biotechnology Revenue, 2023-2028
  6.2.3 By Region - Global Clinical Stage Biotechnology Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Clinical Stage Biotechnology Revenue, 2017-2028
  6.3.2 US Clinical Stage Biotechnology Market Size, 2017-2028
  6.3.3 Canada Clinical Stage Biotechnology Market Size, 2017-2028
  6.3.4 Mexico Clinical Stage Biotechnology Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Clinical Stage Biotechnology Revenue, 2017-2028
  6.4.2 Germany Clinical Stage Biotechnology Market Size, 2017-2028
  6.4.3 France Clinical Stage Biotechnology Market Size, 2017-2028
  6.4.4 U.K. Clinical Stage Biotechnology Market Size, 2017-2028
  6.4.5 Italy Clinical Stage Biotechnology Market Size, 2017-2028
  6.4.6 Russia Clinical Stage Biotechnology Market Size, 2017-2028
  6.4.7 Nordic Countries Clinical Stage Biotechnology Market Size, 2017-2028
  6.4.8 Benelux Clinical Stage Biotechnology Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Clinical Stage Biotechnology Revenue, 2017-2028
  6.5.2 China Clinical Stage Biotechnology Market Size, 2017-2028
  6.5.3 Japan Clinical Stage Biotechnology Market Size, 2017-2028
  6.5.4 South Korea Clinical Stage Biotechnology Market Size, 2017-2028
  6.5.5 Southeast Asia Clinical Stage Biotechnology Market Size, 2017-2028
  6.5.6 India Clinical Stage Biotechnology Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Clinical Stage Biotechnology Revenue, 2017-2028
  6.6.2 Brazil Clinical Stage Biotechnology Market Size, 2017-2028
  6.6.3 Argentina Clinical Stage Biotechnology Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Clinical Stage Biotechnology Revenue, 2017-2028
  6.7.2 Turkey Clinical Stage Biotechnology Market Size, 2017-2028
  6.7.3 Israel Clinical Stage Biotechnology Market Size, 2017-2028
  6.7.4 Saudi Arabia Clinical Stage Biotechnology Market Size, 2017-2028
  6.7.5 UAE Clinical Stage Biotechnology Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Minoryx
  7.1.1 Minoryx Corporate Summary
  7.1.2 Minoryx Business Overview
  7.1.3 Minoryx Clinical Stage Biotechnology Major Product Offerings
  7.1.4 Minoryx Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.1.5 Minoryx Key News
7.2 Inhibrx
  7.2.1 Inhibrx Corporate Summary
  7.2.2 Inhibrx Business Overview
  7.2.3 Inhibrx Clinical Stage Biotechnology Major Product Offerings
  7.2.4 Inhibrx Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.2.5 Inhibrx Key News
7.3 NovaBiotics
  7.3.1 NovaBiotics Corporate Summary
  7.3.2 NovaBiotics Business Overview
  7.3.3 NovaBiotics Clinical Stage Biotechnology Major Product Offerings
  7.3.4 NovaBiotics Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.3.5 NovaBiotics Key News
7.4 RadioMedix
  7.4.1 RadioMedix Corporate Summary
  7.4.2 RadioMedix Business Overview
  7.4.3 RadioMedix Clinical Stage Biotechnology Major Product Offerings
  7.4.4 RadioMedix Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.4.5 RadioMedix Key News
7.5 Artax Biopharma
  7.5.1 Artax Biopharma Corporate Summary
  7.5.2 Artax Biopharma Business Overview
  7.5.3 Artax Biopharma Clinical Stage Biotechnology Major Product Offerings
  7.5.4 Artax Biopharma Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.5.5 Artax Biopharma Key News
7.6 Ribon Therapeutics
  7.6.1 Ribon Therapeutics Corporate Summary
  7.6.2 Ribon Therapeutics Business Overview
  7.6.3 Ribon Therapeutics Clinical Stage Biotechnology Major Product Offerings
  7.6.4 Ribon Therapeutics Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.6.5 Ribon Therapeutics Key News
7.7 Brickell Biotech
  7.7.1 Brickell Biotech Corporate Summary
  7.7.2 Brickell Biotech Business Overview
  7.7.3 Brickell Biotech Clinical Stage Biotechnology Major Product Offerings
  7.7.4 Brickell Biotech Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.7.5 Brickell Biotech Key News
7.8 Coave Therapeutics
  7.8.1 Coave Therapeutics Corporate Summary
  7.8.2 Coave Therapeutics Business Overview
  7.8.3 Coave Therapeutics Clinical Stage Biotechnology Major Product Offerings
  7.8.4 Coave Therapeutics Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.8.5 Coave Therapeutics Key News
7.9 Edesa Biotech
  7.9.1 Edesa Biotech Corporate Summary
  7.9.2 Edesa Biotech Business Overview
  7.9.3 Edesa Biotech Clinical Stage Biotechnology Major Product Offerings
  7.9.4 Edesa Biotech Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.9.5 Edesa Biotech Key News
7.10 CellCentric
  7.10.1 CellCentric Corporate Summary
  7.10.2 CellCentric Business Overview
  7.10.3 CellCentric Clinical Stage Biotechnology Major Product Offerings
  7.10.4 CellCentric Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.10.5 CellCentric Key News
7.11 LimmaTech Biologics AG
  7.11.1 LimmaTech Biologics AG Corporate Summary
  7.11.2 LimmaTech Biologics AG Business Overview
  7.11.3 LimmaTech Biologics AG Clinical Stage Biotechnology Major Product Offerings
  7.11.4 LimmaTech Biologics AG Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.11.5 LimmaTech Biologics AG Key News
7.12 Adaptive Phage Therapeutics
  7.12.1 Adaptive Phage Therapeutics Corporate Summary
  7.12.2 Adaptive Phage Therapeutics Business Overview
  7.12.3 Adaptive Phage Therapeutics Clinical Stage Biotechnology Major Product Offerings
  7.12.4 Adaptive Phage Therapeutics Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.12.5 Adaptive Phage Therapeutics Key News
7.13 Intra-ImmuSG
  7.13.1 Intra-ImmuSG Corporate Summary
  7.13.2 Intra-ImmuSG Business Overview
  7.13.3 Intra-ImmuSG Clinical Stage Biotechnology Major Product Offerings
  7.13.4 Intra-ImmuSG Clinical Stage Biotechnology Revenue in Global Market (2017-2022)
  7.13.5 Intra-ImmuSG Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Clinical Stage Biotechnology Market Opportunities & Trends in Global Market
Table 2. Clinical Stage Biotechnology Market Drivers in Global Market
Table 3. Clinical Stage Biotechnology Market Restraints in Global Market
Table 4. Key Players of Clinical Stage Biotechnology in Global Market
Table 5. Top Clinical Stage Biotechnology Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Clinical Stage Biotechnology Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Clinical Stage Biotechnology Revenue Share by Companies, 2017-2022
Table 8. Global Companies Clinical Stage Biotechnology Product Type
Table 9. List of Global Tier 1 Clinical Stage Biotechnology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Clinical Stage Biotechnology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Clinical Stage Biotechnology Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Clinical Stage Biotechnology Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Clinical Stage Biotechnology Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Clinical Stage Biotechnology Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Clinical Stage Biotechnology Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Clinical Stage Biotechnology Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Clinical Stage Biotechnology Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Clinical Stage Biotechnology Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Clinical Stage Biotechnology Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Clinical Stage Biotechnology Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Clinical Stage Biotechnology Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Clinical Stage Biotechnology Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Clinical Stage Biotechnology Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Clinical Stage Biotechnology Revenue, (US$, Mn), 2023-2028
Table 30. Minoryx Corporate Summary
Table 31. Minoryx Clinical Stage Biotechnology Product Offerings
Table 32. Minoryx Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 33. Inhibrx Corporate Summary
Table 34. Inhibrx Clinical Stage Biotechnology Product Offerings
Table 35. Inhibrx Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 36. NovaBiotics Corporate Summary
Table 37. NovaBiotics Clinical Stage Biotechnology Product Offerings
Table 38. NovaBiotics Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 39. RadioMedix Corporate Summary
Table 40. RadioMedix Clinical Stage Biotechnology Product Offerings
Table 41. RadioMedix Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 42. Artax Biopharma Corporate Summary
Table 43. Artax Biopharma Clinical Stage Biotechnology Product Offerings
Table 44. Artax Biopharma Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 45. Ribon Therapeutics Corporate Summary
Table 46. Ribon Therapeutics Clinical Stage Biotechnology Product Offerings
Table 47. Ribon Therapeutics Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 48. Brickell Biotech Corporate Summary
Table 49. Brickell Biotech Clinical Stage Biotechnology Product Offerings
Table 50. Brickell Biotech Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 51. Coave Therapeutics Corporate Summary
Table 52. Coave Therapeutics Clinical Stage Biotechnology Product Offerings
Table 53. Coave Therapeutics Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 54. Edesa Biotech Corporate Summary
Table 55. Edesa Biotech Clinical Stage Biotechnology Product Offerings
Table 56. Edesa Biotech Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 57. CellCentric Corporate Summary
Table 58. CellCentric Clinical Stage Biotechnology Product Offerings
Table 59. CellCentric Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 60. LimmaTech Biologics AG Corporate Summary
Table 61. LimmaTech Biologics AG Clinical Stage Biotechnology Product Offerings
Table 62. LimmaTech Biologics AG Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 63. Adaptive Phage Therapeutics Corporate Summary
Table 64. Adaptive Phage Therapeutics Clinical Stage Biotechnology Product Offerings
Table 65. Adaptive Phage Therapeutics Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)
Table 66. Intra-ImmuSG Corporate Summary
Table 67. Intra-ImmuSG Clinical Stage Biotechnology Product Offerings
Table 68. Intra-ImmuSG Clinical Stage Biotechnology Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Clinical Stage Biotechnology Segment by Type in 2021
Figure 2. Clinical Stage Biotechnology Segment by Application in 2021
Figure 3. Global Clinical Stage Biotechnology Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Clinical Stage Biotechnology Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Clinical Stage Biotechnology Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Clinical Stage Biotechnology Revenue in 2021
Figure 8. By Type - Global Clinical Stage Biotechnology Revenue Market Share, 2017-2028
Figure 9. By Application - Global Clinical Stage Biotechnology Revenue Market Share, 2017-2028
Figure 10. By Region - Global Clinical Stage Biotechnology Revenue Market Share, 2017-2028
Figure 11. By Country - North America Clinical Stage Biotechnology Revenue Market Share, 2017-2028
Figure 12. US Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Clinical Stage Biotechnology Revenue Market Share, 2017-2028
Figure 16. Germany Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 17. France Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Clinical Stage Biotechnology Revenue Market Share, 2017-2028
Figure 24. China Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 28. India Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Clinical Stage Biotechnology Revenue Market Share, 2017-2028
Figure 30. Brazil Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Clinical Stage Biotechnology Revenue Market Share, 2017-2028
Figure 33. Turkey Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Clinical Stage Biotechnology Revenue, (US$, Mn), 2017-2028
Figure 37. Minoryx Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Inhibrx Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. NovaBiotics Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. RadioMedix Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Artax Biopharma Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Ribon Therapeutics Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Brickell Biotech Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Coave Therapeutics Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Edesa Biotech Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CellCentric Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. LimmaTech Biologics AG Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Adaptive Phage Therapeutics Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Intra-ImmuSG Clinical Stage Biotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)